Follicular lymphoma grade II, in remission is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. This condition is clinically significant as it indicates a stage where the disease has responded to treatment, allowing for better management and monitoring. The ICD-10 Code C82.1A facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track patient outcomes and resource utilization.
ICD-10 Code C82.1A represents Follicular lymphoma grade II, in remission, a subtype of non-Hodgkin lymphoma that is characterized by a moderate proliferation of neoplastic B-cells. This code is used when a patient has achieved remission following treatment, indicating a favorable response to therapy. It is essential for clinical documentation and billing to accurately reflect the patient's current health status and treatment outcomes.
Follicular lymphoma grade II, in remission, is a hematological malignancy that arises from the transformation of B-lymphocytes in the germinal centers of lymphoid follicles. The condition can progress slowly and may require ongoing monitoring even in remission. Medical attention is crucial to manage potential relapses and complications.
ICD-10 Code C82.1A is utilized in SOAP notes to document the patient's remission status, guiding treatment decisions and follow-up care. It plays a vital role in both acute and chronic care settings, ensuring that the patient's health records accurately reflect their current condition and treatment plan.
In SOAP notes, ICD-10 Code C82.1A connects subjective patient reports and objective clinical findings to a formal diagnosis of Follicular lymphoma grade II, in remission. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Follicular lymphoma grade II, in remission, focuses on monitoring and supportive care. While the disease is in remission, treatment may include observation or maintenance therapy as needed.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C82.1A is crucial for accurate billing in hospital, ER, or outpatient settings, particularly for patients in remission.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, low complexity. |
| 85025 | Complete blood count with differential. |
| 36415 | Collection of venous blood by venipuncture. |
Common Questions About Using ICD-10 Code C82.1A for Follicular lymphoma grade II, in remission
What does it mean for Follicular lymphoma to be in remission?
Remission indicates that the signs and symptoms of Follicular lymphoma have significantly decreased or disappeared following treatment. This does not mean the cancer is cured, but it is a positive sign of response to therapy.
How often should patients with Follicular lymphoma in remission be monitored?
Patients in remission typically require follow-up visits every 3 to 6 months to monitor for any signs of recurrence and to manage any ongoing symptoms or treatment side effects.
Can Follicular lymphoma grade II return after remission?
Yes, Follicular lymphoma can relapse after remission. Continuous monitoring is essential to detect any recurrence early and to initiate appropriate treatment.
What are the common treatments for Follicular lymphoma grade II?
Treatment options may include watchful waiting, chemotherapy, immunotherapy, or targeted therapy, depending on the patient's specific situation and response to previous treatments.
Clinical Notes
SOAP notes
DAP notes
AI medical notes